FOR IMMEDIATE RELEASE: Monday, March 19, 2007
CONTACT: Lance M. Westerhoff, 814-235-6908, lance@quantumbioinc.com
State College, PA – March 19, 2007. QuantumBio Inc., headquartered in State College, PA with offices in Gainesville, FL and Lancaster, PA, has released version 4.5 of its DivCon software suite. Based upon technology originally developed at the Pennsylvania State University in the laboratory of Dr. Kenneth Merz Jr., DivCon is the first to target drug discovery teams at pharmaceutical and biotechnology firms with patent pending applications of linear scaling, quantum mechanics methods.
The innovations in version 4.5, built on those of previous versions, allow the user to more easily integrate the tool with his or her computer aided drug discovery workflow through more robust encapsulation of the Company’s patent pending, QMScore technology; better support for standard coordinate file formats; and improved ease-of-use and stability characteristics.
Dr. Lance Westerhoff, General Manager of QuantumBio says: “We think that version 4.5 is the best DivCon version we have released to date with the usability needs of the user in mind. With version 4.5 and its support for standard file formats, better command line options, and significant implementation and stability improvements, the user is able to access the methods much more quickly.”
In support for the new version, QuantumBio’s Support website has also been updated with new documentation. These pages will continue to be updated in the days and weeks to come with additional resources including further examples and publication abstracts pertaining to the technology. Users are also invited to submit their own experiences and publication abstracts to be included on the site. Please visit https://www.quantumbioinc.com/Support/ for more information.
DivCon Version 4.5 (serial) for Linux, Mac OS X, and IRIX will begin shipping this week to all customers with current software license contracts. The parallel (MPI) version, available for Linux and Mac OS X, will ship early next month. New customers are invited to email sales@quantumbioinc.com or visit https://www.quantumbioinc.com/ concerning licensing opportunities.
About QuantumBio:
QuantumBio Inc is accelerating drug discovery efforts by providing pharmaceutical, biotechnology companies and life science research organizations with a next generation of Computer-Assisted Drug Design (CADD) and Computer-Assisted Molecular Modeling (CAMM) solutions based on the increased accuracy and power of quantum mechanics. These solutions include a number of options tailored to each customer’s specific requirements including software licensing, services, and customization. Additional information is available at https://www.quantumbioinc.com or by email sales@quantumbioinc.com.